Introduction
Feline leukemia virus (FeLV)' is a replication-competent retrovirus that is associated with a wide spectrum of hematologic 1 . Abbreviations used in this paper: BFU-E, erythroid burst-forming cell; CFU-E, erythroid colony-forming cell; CFU-GM, granulocytemacrophage colony-forming cell; FACS, fluorescence-activated cell sorter; AFCS, heat-inactivated fetal calf serum; FEA, feline embryonic fibroblasts; FeLV, feline leukemia virus; FeLV-C, FeLV subgroup C/ Sarma; PNH, paroxysmal nocturnal hemoglobinuria; PRCA, pure red cell aplasia. disorders in cats including leukemia, lymphoma, myelodysplastic syndromes, immunosuppression, and nonregenerative anemia (1) (2) (3) . In the laboratory, cats infected with FeLV subgroup C/Sarma (FeLV-C) develop pure red cell aplasia (PRCA) characterized by severe anemia, reticulocytopenia, and the absence of hemoglobinized cells in the marrow (4) (5) (6) . Despite this abnormality in erythropoiesis, granulocytic and megakaryocytic morphology and maturation are normal. When marrow from cats with PRCA is cultured in vitro, no erythroid colonies (from erythroid colony-forming cells [CFU-E] ) are detected. However, normal numbers of erythroid bursts (from erythroid burst-forming cells [BFU-EJ) persist, implying that BFU-E can differentiate in vitro to the hemoglobinized cells comprising erythroid bursts but not in vivo to CFU-E (6) .
Previously, we investigated if cellular or humoral interactions were responsible for the PRCA in FeLV-C-infected cats. Our studies failed to implicate T lymphocytes or circulating antibodies in the pathogenesis of the disease (7) . In other experiments, we showed that BFU-E from cats with PRCA have increased cell cycle kinetics and an altered response to hematopoietic growth factor(s) (8) , suggesting that an abnormality intrinsic to BFU-E may lead to impaired differentiation and result in anemia. For this reason, we have investigated if erythroid progenitors were infected with FeLV-C using antibodies directed at the dominant virus envelope glycoprotein, gp70, which incorporates in the membrane of cells productively infected with retrovirus. Fluorescence-activated cell sorter (FACS) analysis using monoclonal antibodies to gp7O indicated that committed hematopoietic progenitors (BFU-E, CFU-E, and granulocyte-macrophage colony-forming cells [CFU-GM]) were infected with FeLV-C. When confirming these studies with complement (C') lysis experiments, we found that BFU-E from cats with PRCA were uniquely sensitive to the lytic action of heterologous C' in the absence of exogenous antibody.
Methods
General methods. The animals used for these studies were the female F. offspring of matings between Geoffroy and domestic cats (6) . The protocols for infection, for obtaining and processing specimens, and for the assay of feline CFU-E-, BFU-E-, and CFU-GM-derived colonies in methylcellulose culture have been reported (6, 8) . Unless specifically noted, cells were cultured in the presence of0.5 U/ml ofpartially purified human urinary erythropoietin and a 5% concentration of medium conditioned by feline embryonic fibroblasts (FEA) infected with FeLV-A/Glasgow-l (9) . The percentage of feline hematopoietic progenitors in active DNA synthesis was determined using the titiated thymidine suicide technique as reported previously (8) .
FACS studies. To determine if feline hematopoietic progenitors were infected with retrovirus, marrow mononuclear cells were labeled with affinity-purified monoclonal antibodies C IID8 and/or G13D8 to gp70 (10 For FACS analysis, the positive cutoffwas determined so that 1-4% of marrow cells treated with an irrelevant first antibody or alpha medium would sort positively. Cells in the positive and negative fractions were counted and then plated in methylcellulose culture, generally at a concentration of 2.5 X 104 cells/ml.
Complement lysis studies. To confirm the FACS results, C' lysis studies were performed. For these experiments, 106 marrow mononuclear cells were incubated in 100 Ml HBSS/0. 1% BSA for 1 h at room temperature with monoclonal antibodies Cl D8 and G13D8 (final concentration, 6.25 ug/ml for each antibody), the 1 h at 370C with baby rabbit serum as the source of C' (1:1 vol/vol; Pel Freeze Biologicals, Rogers, AR). The cells were then washed with HBSS, resuspended to their original volume with alpha medium, and plated in methylcellulose. Our preliminary studies confirmed that concurrent incubation with C 1 D8 and G I 3D8, which mark distinct epitopes of gp7O, amplified the C' lysis effect (10) . As Heat-inactivated serum served as a control. The response ofthe thawed cells to baby rabbit C' was similar to that seen in studies with fresh marrow mononuclear cells (data not shown). Specifically, 5% ofdetectable BFU-E remained when these stored 64550 PRCA marrow mononuclear cells were exposed to baby rabbit C'.
In additional experiments, we examined the relationship of the C' sensitivity of BFU-E to cell cycle kinetics and retrovirus infection. Studies were performed on marrow from two normal cats before and after anemia was induced with 50 mg/kg phenylhydrazine (Sigma Chemical Co., St. Louis, MO) given intraperitoneally, followed by phlebotomy. Similar experiments were performed in two cats viremic with FeLV-A/Glasgow-l, which is not associated with hematological abnormalities (14) , and in one cat viremic with the Rickard strain of FeLV (15, 16) . 2 mo after these studies, this cat developed a thymic lymphoma.
Suspension cultures. To determine if cells less differentiated than BFU-E were infected with FeLV-C or were sensitive to C', marrow mononuclear cells were treated as above with antibodies to gp70 or AFCS and then C' or AFCS. These cells were then resuspended to their initial volume and placed in suspension cultures containing 1 ml of alpha medium with all the ingredients of methylcellulose culture except the methylcellulose (8) . After a 2-d incubation at 370C in 4% CO2 in air, residual cells were washed, resuspended in 1 ml of alpha medium, and the frequencies of progenitors were assayed in methylcellu- three times with HBSS. The cells were next incubated with Cl 1D8 and G13D8 or AFCS, followed by baby rabbit C' as described above, before being plated in methylcellulose. As a control, some cells were incubated initially with FEA supernatant. In additional studies designed to determine ifimmune complexes were adsorbed by hematopoietic cells, sera from cats with PRCA were used for the first incubation step.
Results
FACS studies. To determine if erythroid progenitors were uniquely infected with FeLV-C, FACS studies were performed with marrow from two cats with PRCA (four experiments), one cat viremic with FeLV-C before the onset of anemia (two experiments), and two normal cats (three experiments). A representative study of marrow from cat 64977 with PRCA is shown in Fig. 1 . When marrow was incubated with control monoclonal antibody to Thy 1.1 ( Fig. 1 A) , antibody I9B4 ( Fig. 1 B) , or alpha medium (data not shown), and then with flouresceinated rabbit anti-mouse IgG, the distribution of flourescent cells did not change. When treated initially with monoclonal antibody No. 8 ( Fig. 1 C) , -50% of cells were positive. Initial incubation with Cl1 D8 (Fig. 1 D) or GI 3D8 (not shown) shifted the entire fluorescence curve to the right, suggesting that most marrow cells express gp7O.
In this experiment ( Fig. 1 tive." There was no increase in the frequency of BFU-E or CFU-GM in this fraction (Table I) . In additional studies, marrow cells from two normal cats were treated with alpha medium, monoclonal antibody to Thy 1.1, or antibodies Cl 1D8 and Gl 3D8 before incubation with the fluoresceinated second antibody and FACS analysis. The fluorescence distribution curves were identical in these studies (data not shown), suggesting that a determinant antigenically similar to gp7O was not present on normal cells.
Cat 65707 was studied 4 wk after inoculation with FeLV-C. At that time, the fluorescence distribution curve had two peaks, suggesting that a subset of cells expressed gp7O (Fig. 2 A). FACS analysis (Table I) Fluorescence intensity (log scale) gp7O.
BFU-E, and CFU-GM were preferentially found in this fraction. When this cat was studied 7 wk later ( Fig. 2 B) , the fluorescence distribution was similar to that ofcats with PRCA ( Fig. 1 ). These data suggest that most marrow cells were infected at this time. Cell sorting demonstrated that hematopoietic progenitors were among these positive cells (data not shown). C' lysis studies. C' lysis studies were done to confirm that hematopoietic progenitors were infected with FeLV-C, and data representative of studies in four cats with PRCA are presented in Table II . When marrow cells were incubated with the monoclonal antibodies to gp7O and baby rabbit serum as a source of C', their colony-forming ability was significantly decreased, confirming that BFU-E and CFU-GM were infected with retrovirus. In addition, the numbers ofdetectable BFU-E fell with exposure to the C' alone. This result suggested that BFU-E had an enhanced sensitivity to C'-mediated lysis.
In additional studies, when PRCA marrow was incubated with baby rabbit serum as a source of C', the mean (±SE) number of BFU-E detected in vitro was 47±5% of the number of BFU-E detected when marrow was incubated with AFCS (17 experiments). In contrast, 98±3% of baseline BFU-E were detected after the treatment of normal cat marrow with C' (16 experiments in eight cats). The recoveries of CFU-GM after exposure of PRCA or normal marrow cells to C' were 92±2 and 97±2%, respectively. Although the results ofFACS analysis suggest that hematopoietic progenitors from cat 65707 were infected before week 4 after inoculation with FeLV-C (Table I) , C' lysis studies did not demonstrate infection until week 10 (data not shown). At this time, BFU-E first appeared sensitive to C'.
Five studies in two cats that were viremic but had not yet developed anemia also demonstrated that CFU-E, like CFU-GM, were infected but were not unusually sensitive to C' (Table II).
When cultures of marrow cells from a cat with PRCA were examined daily, colonies containing hemoglobinized cells appeared at day 5. 74% of these erythroid bursts were C' sensitive. The cultures were then scored on days 6-12, and the percentages of erythroid bursts sensitive to C' were similar, and were 76, 86, 85, 77, and 82%, respectively.
Characterization of the C' sensitivity of BFU-E. Several studies were undertaken to confirm that the decrease in BFU-E detected after incubation with baby rabbit serum represented enhanced C' sensitivity rather than nonspecific toxicity of the serum. Data in Table III show that near baseline numbers of BFU-E were detected after incubation of PRCA marrow with heat-inactivated baby rabbit serum or serum treated with chelators (EDTA). When marrow was incubated with baby rabbit serum, EGTA and MgCl2, a baseline number of BFU-E persisted, suggesting that C' was activated by the classical pathway. Similar results were obtained with guinea pig serum (Table III) . In addition, incubation of PRCA marrow with C4-deficient guinea pig serum did not inhibit BFU-E growth, confirming that the C' effect was mediated via the classical pathway. Our results could not be reproduced with fresh cat serum as a C' source (Table III) In other studies, marrow from a cat with PRCA was incubated for 0, 30, 60, 90, or 120 min with baby rabbit serum. At each of these time points, respectively, 62±3 (mean±SE), 34+2, 27+1, 22±2, and 18±2 BFU-E were detected; the numbers of CFU-GM detected, however, remained unchanged (17±2 at baseline and 16±1 at 120 min). In a separate experiment, marrow from a viremic cat was studied after a 4-h exposure to baby rabbit serum or AFCS. With AFCS, 187±7 BFU-E and 50±4 CFU-GM were detected. After 4 h of C' exposure, 6±1 BFU-E and 58±7 CFU-GM remained, confirming the resistance of CFU-GM to in vitro C' lysis.
Studies were undertaken to determine if BFU-E infected with FeLV-C were uniquely sensitive to C' lysis or if this was a general property of retrovirus-infected BFU-E or BFU-E with accelerated cell cycle kinetics. Representative studies, shown in Table IV , indicated that neither increased cell cycle kinetics nor evidence of progenitor infection with the Rickard strain of FeLV or FeLV-A/Glasgow-I was associated with an increased C' sensitivity of BFU-E. Suspension culture studies. Suspension cultures of marrow from cats with PRCA were used to determine if progenitors less differentiated than BFU-E were also C' sensitive and infected. A representative study is shown in Table V . Pretreatment of marrow with C' or monoclonal antibodies to gp7O then C' decreased the number of BFU-E that were placed in suspension culture. However, after 2 d of suspension culture, nearly as many BFU-E were detected in cultures from marrow treated on day 0 with C' as were detected in control cultures treated day 0 with AFCS, suggesting that BFU-E were recruited from an earlier population that was not sensitive to C'. In contrast, the numbers ofBFU-E remained low in cultures of marrow treated on day 0 with antibodies to gp7O then C'. These studies indicate that although earlier erythroid progenitors are infected with retrovirus, C' sensitivity develops at the BFU-E stage of differentiation.
Studies ofgp70 binding to normal progenitors. Additional studies were designed to confirm that the gp70 present on the surface on progenitor cells resulted from retroviral infection and not from the nonspecific adsorption of FeLV, FeLV protein, or immune complexes present in the serum of cats with PRCA. As shown in Table VI , after incubation of normal marrow with PRCA sera, gpO could not be detected on the surface of progenitor cells with the C' lysis assay. However, when studies were performed with supernatant from FEA infected with FeLV-C, gp7O was detected on CFU-E and BFU-E, but not on CFU-GM. As binding persisted at 4°C and with heat inactivation of virus, these studies suggest that normal erythroid (but not granulocyte-macrophage) progenitors express a receptor specific for gp70. Similar results were obtained when normal marrow was incubated with supernatant from FEA infected with FeLV-A/Glasgow-l (data not shown).
In additional studies it was determined. if binding of gp7O or FeLV-C alone were sufficient to render BFU-E sensitive to C' lysis. Because others have reported the human and cat (but not rabbit) serum may bind directly to the transmembrane envelope protein p1 5E of several retroviruses (17, 18) , normal marrow cells initially treated with FeLV-C were then incubated with AFCS, fresh human serum, or fresh normal cat serum as well as baby rabbit serum. The results ofthese studies (data not shown) failed to demonstrate a relationship between the presence of FeLV-C or viral protein on BFU-E and C' sensitivity, and therefore suggest that C' sensitivity reflects progenitor infection and disease progression.
Discussion
Many viruses, including hepatitis, Epstein-Barr virus, and parvovirus, have been associated with erythroid marrow failure; and T cell-mediated inhibition of erythropoiesis, aberrant antibody formation, and direct viral infection of erythroid progenitors have been suggested as the mechanisms underlying (16) .
A second strategy is to look for the presence of viral envelope proteins on the surface of progenitor cells with FACS or C' lysis studies. If cells express gp7O, one may infer that provirus is integrated into the genome, and that after the transcription and translation of viral sequences, envelope protein is incorporated into the host cell membrane. This approach has been used to demonstrate that Friend virus complex infects murine CFU-GM (24) .
Our FACS and C' lysis studies with monoclonal antibodies Cl 1D8 and G13D8 demonstrated that BFU-E, CFU-E, and CFU-GM from cats viremic with FeLV-C expressed gp70. Data from 2-d suspension cultures also suggested that earlier hematopoietic progenitors were productively infected with FeLV, consistent with the experience with murine retroviruses that have been used as vectors to incorporate foreign material into multipotent hematopoietic stem cells (25, 26) .
A potential concern in interpretation of these data is that gp7O present in the serum ofviremic cats could nonspecifically bind to hematopoietic progenitors and, if so, the presence of gp7O on the surface of cells might not reflect the productive infection of that cell with retrovirus. To test this hypothesis directly, we incubated nornial cat marrow with virus and viral protein under optimal conditions for nonspecific binding. After this incubation, gp7O could be detected on erythroid but not granulocyte-macrophage progenitor cells (Table VI) . When marrow cells were incubated at 4°C with virus and then extensively washed before study, gp7O was also detected on erythroid progenitors with the C' lysis assay, suggesting that the glycoprotein binds to a specific receptor. As the binding of gp7O to a cell surface receptor is the mode by which a retrovirus infects a cell, these data raise the possibilities that erythroid progenitors are more susceptible than granulocytic progenitors to retroviral infection, or that more viral proteins may be present on the surface of committed erythroid cells. The relationship of this finding to the pathogenesis of feline PRCA is speculative.
As the concentrations of FeLV-C, viral proteins, or immune complex present in the sera of cats with PRCA are insufficient to result in detectable gp7O binding to normal erythroid progenitors (Table VI) , the results of our studies of viremic cat marrow are most consistent with the conclusion that erythroid progenitors are productively infected with retrovirus. It is possible, however, that the binding of FeLV-C to progenitors is dependent on the local production of retrovirus by marrow cells and not the serum virus concentration. More importantly, as CFU-GM from normal cats do not bind exogenous gp7O, our studies clearly demonstrate that these progenitors from cats viremic with FeLV-C are infected and that infection occurs as early as 4 wk after viral inoculation. Hence, the infection oferythroid progenitors, per se, is not the cause of feline PRCA.
In confirming our FACS studies with C' lysis experiments, we observed that BFU-E from cats with PRCA were unusually sensitive in vitro to the lytic action of heterologous C' alone. This enhanced sensitivity appeared to result from C' activation via the classical pathway. Further studies indicated that C' sensitivity was not a property of CFU-E, CFU-GM, or progenitors that were capable of giving rise to BFU-E in suspension culture.
In addition, we determined if C' sensitivity was a property of BFU-E with altered cell cycle kinetics. Our previous studies using tritiated thymidine demonstrated that after FeLV-C infection, 43±4% (SD) of BFU-E are in DNA synthesis (normal 23±2%), while the cell cycle kinetics of CFU-GM are normal (8) . Thus, we investigated if BFU-E in rapid cell cycle after phenylhydrazine and phlebotomy were sensitive to C' lysis. Although BFU-E were activated into cell cycle as a result ofthe anemia (46% in DNA synthesis), there was no evidence of increased C' sensitivity.
The Rickard strain of FeLV induces a thymic lymphosarcoma, and not anemia (16) . Our studies of marrow from a cat viremic with Rickard-FeLV (Table IV) indicated that hematopoietic progenitors are infected but not sensitive to C'. Similar results were obtained in studies of marrow from cats viremic with FeLV-A/Glasgow-l (Table IV) . Therefore, C' sensitivity is not a general property of retrovirus-infected BFU-E.
There are several mechanisms that might explain the unusual C' sensitivity of BFU-E from cats viremic with FeLV-C. First, antibody to viral protein and/or a BFU-E membrane determinant may be present in the serum of viremic cats and bind to BFU-E in vivo, causing the progenitor to be sensitive to C' in vitro. Our initial co-culture studies of PRCA serum with autologous or normal marrow did not support this premise (7).
Second, cat Clq might bind directly to a viral envelope protein on the BFU-E membrane and initiate C' activation.
Others have reported that feline or human Clq can bind directly to the p1 5E of several retroviruses, resulting in C' activation and viral lysis (17, 18, 27, 28) . Although intact virus may be lysed by this mechanism, direct C' activation by virally infected nucleated cells has not been reported (28) . For BFU-E to be detected in culture, they must mature and differentiate to hemoglobinized cells. Therefore, one possibility, consistent with our results and with the finding of normal frequencies of BFU-E in marrow of cats with PRCA, is that C' does not lyse cells but, rather, damages the membrane in such a way that BFU-E differentiation is specifically impaired.
Third, FeLV-C infection alone could somehow alter the BFU-E cell membrane and lead to increased C' sensitivity. In considering this mechanism, it is tempting to draw parallels with the C' sensitivity of BFU-E in feline PRCA and PNH in man. PNH is a clonal disorder of the hematopoietic stem cell that classically presents as hemolysis with hemoglobinuria, but may be associated with pancytopenia (29) (30) (31) . PNH erythrocytes lack acetylcholinesterase on their surface (32) and circulating cells are C' sensitive (33) . Demonstration of C' sensitivity requires the exposure of PNH cells to acidified serum (12) or to serum in the presence of a low ionic strength sucrose solution (13) . These manipulations further activate the alternate and classical C' pathways, respectively. Some studies (34) suggest that BFU-E from patients with PNH are C' sensitive, while others (35) demonstrate that the defect is acquired subsequently during maturation towards red cells. It is thought that the absence of decay-accelerating factor is responsible for decreased C3b convertase activity, and leads to the increased stability of C3b and increased C' activation (33, 36, 37) . In contrast to PNH, our studies in glucose-6-phosphate dehydrogenase heterozygous cats have demonstrated that feline PRCA is not a clonal disorder of the myeloid stem cell (6) . Complement activation is via the classical, and not the alternate, pathway. We could not demonstrate sensitivity of marrow progenitors to acidified cat serum or to a low ionic strength sucrose solution. The possible lysis of differentiated cells was not studied with these assays.
As our studies with heterologous C' could not be repeated with fresh cat serum as the C' source (Table III) , the relevance of our studies to pathogenesis of PRCA in vivo is more difficult to assess. However, Grant et al. (38) have reported that cat C' is uniquely slow in its action, requiring 8-20 h for lysis of antibody-coated cells.
We hypothesize, therefore, that feline PRCA results from the C' sensitivity of retrovirus-infected BFU-E. As cats with PRCA have normal numbers of BFU-E, and no detectable CFU-E (6), it is this stage of differentiation that is impaired in vivo. It is of interest that cats in the community with FeLVassociated anemia have decreased levels of serum C' (39) , which is consistent with the consumption of C' proteins.
